Viewing Study NCT04763408


Ignite Creation Date: 2025-12-26 @ 10:57 AM
Ignite Modification Date: 2026-03-01 @ 12:26 PM
Study NCT ID: NCT04763408
Status: COMPLETED
Last Update Posted: 2024-07-18
First Post: 2021-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma
Sponsor: Eisai Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module